Literature DB >> 32519252

Efficient Allitol Bioproduction from D-Fructose Catalyzed by Recombinant E. coli Whole Cells, and the Condition Optimization, Product Purification.

Xin Wen1, Huibin Lin2, Yilin Ren3, Can Li4, Chengjia Zhang1, Xin Song5, Jianqun Lin1, Jianqiang Lin6.   

Abstract

Allitol is a kind of rare sugar alcohol with potential application value. An engineered strain, which simultaneously expressed D-psicose-3-epimerase (DPE), ribitol dehydrogenase (RDH), and formate dehydrogenase (FDH) three enzymes, was constructed by cloning above three genes into one plasmid and transformed into the host E. coli strain, and used as the whole-cell catalysts for biotransformation of allitol from the low-cost substrate of D-fructose. The whole cell allitol biotransformation conditions were optimized. The medium, recombinant gene induction conditions, and the substrate feeding rate for cultivation of the catalytic cells were optimized. Then, the fed-batch culture was made and scaled up to 10 L fermentor. Finally, 63.44 g/L allitol was obtained from 100 g/L D-fructose after 3 h of biotransformation, and the allitol crystals of 99.9% purity were obtained by using cooling recrystallization. The allitol production method developed in this research has high product purity, and is highly efficient, easily scaled up, and suitable for large-scale production of highly purified allitol.

Entities:  

Keywords:  Allitol; Cooling crystallization; D-fructose; Fed-batch culture; Whole-cell biotransformation

Mesh:

Substances:

Year:  2020        PMID: 32519252     DOI: 10.1007/s12010-020-03359-x

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  1 in total

1.  D-Allulose (D-Psicose) Biotransformation From Allitol by a Newly Found NAD(P)-Dependent Alcohol Dehydrogenase From Gluconobacter frateurii NBRC 3264 and the Enzyme Characterization.

Authors:  Xin Wen; Huibin Lin; Yuhang Ning; Guangwen Liu; Yilin Ren; Can Li; Chengjia Zhang; Jianqun Lin; Xin Song; Jianqiang Lin
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.